ATM Sequencing

185
RNA was isolated from 5 x 10 6 of CCRF-CEM, MOLT-4 or SUP-B15 cells using SV 186 total RNA isolation kit (Promega, VIC, Australia). Reverse transcription was performed using 187 the ImProm-IITM Reverse transcription system (Promega, VIC, Australia) kit. 1 μg of RNA 188 samples were mixed with 0.5 μg of oligo dT, 0.5 μg of random primers and nuclease-free water.
189 The reverse transcription mix was prepared according to the Promega protocol. RNA and 190 primers were combined with reverse transcription mixture and incubated accordingly:
191 Annealing at 25° C for 5 minutes; extension at 42° C for one hour and reverse transcriptase 192 inactivation by incubation at 70° C for 15 minutes. The cDNA product was stored at -20° C 193 prior to use.
194
Primers were designed to ensure that the entire coding region of the Ataxia-195 telangiectasia mutated (ATM) gene was amplified (Fig 1) . (Fig 2A) . The level of reduction in cell density was about 50% compared to the 232 control after 4 hours (0.56 ± 0.05, P = 0.0018), and remained at these levels after 12 hours (0.54 233 ± 0.04, P = 0.0011) and (0.57 ± 0.02, P = 0.014) 24 hours. CCRF-CEM cells exposed to 234 daunorubicin (Fig 2B) did not show significant reduction in cell density until 12 hours in the 235 recovery media (0.48 ± 0.07, P = 0.0002) compared to the control. The significant reduction in 236 the cell density level remained after 24 hours recovery (0.45 ± 0.07, P < 0.0001). Treatment of 237 SUP-B15 cells (Fig 2C) with daunorubicin resulted in a biphasic response. Initially after 4 238 hours in recovery media there was a significant decrease in cell density compared to the control 239 (0.61 ± 0.07, P = 0.006). When the cells were incubated in 12 hours recovery media, the 240 decrease in cell density was comparable to the control (1.08 ± 0.07) and not significantly 241 reduced at 24 hours (0.76 ± 0.06; P = 0.945). Fig 3A) with 10 μM daunorubicin resulted in a 259 significant increase in ROS production after 4 hour recovery period (10.48 ± 0.03, P < 0.0001) 260 compared to the control. Increase in ROS production reached a maximum after 12 hours 261 recovery (127.7 ± 2.47, P < 0.0001) and declined significantly after 24 hours (24.90 ± 0.40, P 262 < 0.0001). CCRF-CEM cells exposed to daunorubicin (Fig 3B) , displayed a similar pattern of 263 ROS production. There was a significant increase in ROS production after 4 hours recovery 264 period (47.33 ± 0.77, P < 0.0001) compared to the control. This increase in ROS production 265 reached a maximum after 12 hours recovery (133.1 ± 1.95, P < 0.0001), then decreased after 266 24 hours recovery (16.0 ± 0.21, P < 0.0001). SUP-B15 cells (Fig 3C) when treated with 267 daunorubicin did not appear to be as sensitive to the production of ROS compared to MOLT 268 and CCRF-CEM cells. SUP-B15 cells showed a significant increase in ROS production after 269 4 hours recovery period (23.09 ± 3.11, P < 0.0001) compared to the control. The amount of 270 ROS produce was comparable following 12 hours incubation in the recovery media (24.75 ± 271 2.79; P < 0.0001) before declining after 24 hours recovery (9.91 ± 1.46 P = 0.0172). 277 * P < 0.05, ** P < 0.01; *** P < 0.001; **** P < 0.0001 one-way ANOVA followed by Tukey's post-278 hoc test.
279
280 Effects of daunorubicin on DNA double strand breaks 281 The lesions most detrimental to cell survival following treatment with daunorubicin, 282 include the DSBs. The production and subsequent repair of these lesions was assessed over 283 time by detecting γH2AX. This also gives an indication of how effective DNA repair processes 284 are within T or B lymphoblast derived cells (Fig 4 and S2 Fig) . After 4 hours recovery, there 285 was no significant increase in γH2AX fluorescence intensity (2.81 ± 0.88; P = 0.127) compared 286 to the control in MOLT-4 cells (Fig 4A) . However, after 12 hours in recovery media, there was 287 a significant increase in γH2AX expression (3.76 ± 0.57; P = 0.0065). When cells were 288 incubated for 24 hours in the recovery media, γH2AX expression decreased and was 289 comparable to control levels (2.35 ± 0.622; P = 0.423). When CCRF-CEM cells were allowed 290 to recover for 4 hours (Fig 4B) following initial 4 hours treatment with daunorubicin, there was 291 a significant increase in the number of cells that stained positive for γH2AX when compared 292 to the control (3.91 ± 0.54; P = 0.0002). γH2AX expression decreased after 12 hours in recover 293 media, comparable to control levels (2.37 ± 0.38; P = 0.471). Levels of γH2AX remained at 294 this level after 24 hours recovery (2.24 ± 0.69; P = 0.277). When SUP-B15 cells ( Fig 4C) were 295 incubated for 4 hours in recovery media, there was a significant increase in the percentage of 296 cells expressing γH2AX when incubated in the recovery media for 4 hours (2.45 ± 0.45; P = 297 0.0148). Expression levels remained elevated after 12 hours (2.59 ± 0.23; P = 0.0024) and 24 298 hours incubation in the recovery media (3.13 ± 0.43; P < 0.0001). (Fig 6A) . SOD2 was unchanged in both MOLT-4 and CCRF-CEM and 350 increased in SUP-B15 cells (Fig 6B) , although the later effect could be due to reduced ROS 351 production seen in SUP-B15 cells (Fig 3C) . This dysfunction of p53 would also have an impact 352 on cell cycle regulators, including p21 and p27, which are both down regulated in SUP-B15
353 cells following treatment with daunorubicin (Table 1) . 
